ピロリジン誘導体の経口製剤

Title:

ピロリジン誘導体の経口製剤

Document Type and Number:

Japanese Patent JP6479800

Kind Code:

B2

Abstract:

The present invention relates to solid oral formulations comprising a compound of formula (3Z,5 S)-5-(hydroxymethyl)-1-[(2'-methyl-1, 1 '-biphenyl-4-yl)carbonyl]pyrrolidin-3 -one-O-methyloxime, and/or an active metabolite thereof, and the use of said formulations in the treatment and/or prevention of preterm labor, premature birth, dysmenorrhea and embryo implantation failure due to uterine contractions. The present invention is furthermore related to processes for their preparation.

More Like This:

WO/2009/042612	THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND AROMATASE INHIBITORS OR COMBINATIONS OF COX-2 INHIBITORS AND ESTROGEN RECEPTOR ANTAGONISTS
WO/1994/002459	INDOLINYL N-HYDROZYUREA AND N-HYDROXAMIC ACID DERIVATIVES AS LIPOXYGENASE INHIBITORS

Inventors:

Shore, Andre
Paul, Olivier

Application Number:

JP2016534249A

Publication Date:

March 06, 2019

Filing Date:

December 15, 2014

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Obseva S.A.

International Classes:

A61K31/40; A61K9/20; A61K31/573; A61K45/00; A61K47/02; A61K47/14; A61K47/26; A61K47/32; A61K47/34; A61K47/38; A61P15/06; A61P15/08; A61P15/10; A61P25/18; A61P25/28; A61P35/00; A61P43/00

Domestic Patent References:

JP2005533828A
JP2003192582A
JP2009073847A
JP2003516341A
JP2010540588A

Attorney, Agent or Firm:

Longhua International Patent Service Corporation

Previous Patent: 粒子への分子の接合

Next Patent: EQUIPMENT OPERATION MONITORING DEVICE